Company intelligence / Profile preview

Inventia Life Science

Alexandria (Sydney), New South Wales, Australiainventia.life ↗

Ownership: Private
Employees: ~135
Development stage: Other

Overview

Inventia Life Science's RASTRUM platform is commercially available and used by leading research institutes and pharma companies. Their technologies enable research in cancer, neuroscience, and regenerative medicine, such as bioprinted skin for burns. Clinical results in partnered programs are emerging but not publicly detailed

Therapeutic areas: OncologyNeurologyOtherDermatology
Modalities: DeviceBiologicHydrogel-based drug delivery therapyPlatform technology
Industry: Therapeutic Medical Devices

Partnerships

MSD (Merck) for 3D neurodegenerative disease cell modelsPhenoVista Biosciences for imaging-based phenotypic assay preclinical research

Beyond the preview

Go deeper on Inventia Life Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inventia Life Science.